engleski

Diclophenac potassium versus cephtazidime for reduction of post ERCP pancreatitis in average risk patients-randomised controlled trial- interim analysys

Post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is the most common major complication of ERCP. In some cases pancreatitis is followed by severe course with pancreatic necrosis and multiorgan failure. Diclophenac potassium together with indometacine is currently standard treatment in prevention of PEP while ceftazidime is possible alternative treatment for patients with contraindication for nonsteroidal antiimflammatory drugs (NSAID).

acute pancreatitis; ERCP

nije evidentirano